Completed
AZD2115 Single Ascending Dose Study
NCT01283984
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +9 more
- Locations
-
- Research Site London, UK, United Kingdom